Fitbit today came out with some additional news that might give Wall Street some signs of life as it looks to compete with an increasingly complicated fitness tracking environment — and the stock is surging this afternoon as a result.
Fitbit’s shares are up more than 11 percent after it announced a partnership with Dexcom, which would introduce glucose monitoring on the Ionic Smartwatch. This somewhat nudges Fitbit beyond just fitness tracking into something that’s more in the vein of health tracking in general. Starting in 2018, the Fitbit Ionic will show users data from a Dexcom G5 mobile sensor. It’s a collaboration that’s aimed at developing and marketing products to better manage diabetes.
I could see Fitbit being the industry leader they are way a head of everyone else in the health market space.